Evidence map›Paper›PMID 26901559›Full record

ReviewCritical care medicine2016

A Framework for the Development and Interpretation of Different Sepsis Definitions and Clinical Criteria.

Derek C Angus, Christopher W Seymour, Craig M Coopersmith, Clifford S Deutschman, Michael Klompas, Mitchell M Levy, Gregory S Martin, Tiffany M Osborn, Chanu Rhee, R Scott Watson

Abstract readReview
In one paragraph

Review in Critical care medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed
17.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 171 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Urinary microRNAs in sepsis function as a novel prognostic marker.Experimental and therapeutic medicine · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Derek C Angus1Department of Critical Care Medicine, The Clinical Research, Investigation, and Systems Modeling of Acute illness (CRISMA) Center, University of Pittsburgh School of Medicine, Pittsburgh, PA.2Department of Surgery, Emory University School of Medicine, Atlanta, GA.3Department of Pediatrics, Hofstra-North Shore-LIJ School of Medicine, Cohen Children's Medical Center, New Hyde Park, NY.4Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA.5Department of Medicine, Brigham and Women's Hospital, Boston, MA.6Division of Pulmonary/Critical Care Medicine, Alpert Medical School at Brown University, Providence, RI.7Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Critical Care, Emory University School of Medicine, Atlanta, GA.8Departments of Surgery and Emergency Medicine, Washington University School of Medicine, St. Louis, MO.9Department of Pediatrics, Pediatric Critical Care Medicine, University of Washington; Center for Child Health Behavior and Development, Seattle Children's Research Institute, Seattle, WA.
Christopher W Seymour
Craig M Coopersmith
Clifford S Deutschman
Michael Klompas
Mitchell M Levy
Gregory S Martin
Tiffany M Osborn
Chanu Rhee
R Scott Watson
Harvard Pilgrim Health Care · US

Funding

Protocolized Care for Early Septic Shock (ProCESS)P50GM076659 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ANGUS, DEREK C · 2006 to 2012
$11.2M
Preventive and Early Treatment of Acute Lung Injury Clinical Trials Network- Pgh - SupplementU01HL123020 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ANGUS, DEREK C, YEALY, DONALD M · 2014 to 2020
$2.4M
Pre-hospital identification of high-risk sepsisK23GM104022 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SEYMOUR, CHRISTOPHER WARREN · 2013 to 2016
$674k
Immunotherapy of sepsis using anti-PDL1 antibodyR34GM107650 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI ANGUS, DEREK C, HOTCHKISS, RICHARD SAMUEL · 2015 to 2015
$158k
NHLBI NIH HHS HL123020NHLBI NIH HHS U01 HL123020NIGMS NIH HHS GM104022NIGMS NIH HHS GM107650NIGMS NIH HHS K23 GM104022NIGMS NIH HHS P50 GM076659NIGMS NIH HHS R34 GM107650
6 · The paper itself

Abstract

Although sepsis was described more than 2,000 years ago, and clinicians still struggle to define it, there is no "gold standard," and multiple competing approaches and terms exist. Challenges include the ever-changing knowledge base that informs our understanding of sepsis, competing views on which aspects of any potential definition are most important, and the tendency of most potential criteria to be distributed in at-risk populations in such a way as to hinder separation into discrete sets of patients. We propose that the development and evaluation of any definition or diagnostic criteria should follow four steps: 1) define the epistemologic underpinning, 2) agree on all relevant terms used to frame the exercise, 3) state the intended purpose for any proposed set of criteria, and 4) adopt a scientific approach to inform on their usefulness with regard to the intended purpose. Usefulness can be measured across six domains: 1) reliability (stability of criteria during retesting, between raters, over time, and across settings), 2) content validity (similar to face validity), 3) construct validity (whether criteria measure what they purport to measure), 4) criterion validity (how new criteria fare compared to standards), 5) measurement burden (cost, safety, and complexity), and 6) timeliness (whether criteria are available concurrent with care decisions). The relative importance of these domains of usefulness depends on the intended purpose, of which there are four broad categories: 1) clinical care, 2) research, 3) surveillance, and 4) quality improvement and audit. This proposed methodologic framework is intended to aid understanding of the strengths and weaknesses of different approaches, provide a mechanism for explaining differences in epidemiologic estimates generated by different approaches, and guide the development of future definitions and diagnostic criteria.

Indexed as

HumansReproducibility of ResultsSepsis

Identifiers

PMID26901559
PMCPMC4765912
OpenAlexW2334832924

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.